(1) mutagenesis;

(2) the construction and use of somatic animal hybridoma cells (e.g. for the production of monoclonal antibodies);

(3) cell fusion (including protoplast fusion) of cells from plants which can be produced by traditional breeding methods;

(4) self-cloning of non-pathogenic naturally occuring micro-organisms which fulfil the criteria of Group I for recipient micro-organisms.